Prevention of bone loss by using Lactobacillus-fermented milk products in a rat model of glucocorticoid-induced secondary osteoporosis

Agriculture & Biology

• osteoporosis 84%
• fermented milk 75%
• glucocorticoids 66%
• Lactobacillus 59%
• dairy products 59%
• animal models 54%
• bones 52%
• Lactobacillus fermentum 41%
• dexamethasone 33%
• Lactobacillus plantarum 33%
• apoptosis 28%
• gene expression 28%
• bone metabolism 23%
• osteocalcin 21%
• bone morphogenetic proteins 21%
• tibia 17%
• rats 16%
• intestinal microorganisms 15%
• ileum 15%
• acid phosphatase 15%
• signs and symptoms (animals and humans) 14%
• ligands 14%
• adverse effects 12%
• injection 10%
• receptors 10%
• cells 9%
• calcium 9%
• metabolism 9%

Medicine & Life Sciences

• Cultured Milk Products 100%
• Lactobacillus 70%
• Glucocorticoids 56%
• Osteoporosis 54%
• Lactobacillus fermentum 49%
• Lactobacillus plantarum 42%
• Bone and Bones 36%
• Dexamethasone 28%
• Gene Expression 27%
• Integrin-Binding Sialoprotein 22%
• RANK Ligand 20%
• Tartrate-Resistant Acid Phosphatase 20%
• Osteoprotegerin 19%
• Bone Morphogenetic Protein 2 19%
• Apoptosis 18%
• Osteocalcin 16%
• Ileum 15%
• Tibia 15%
• Gastrointestinal Microbiome 15%
• Calcium 10%
• Injections 8%
• Population 6%
• Therapeutics 5%